Menopause, lung function and obstructive lung disease outcomes: a systematic review

被引:26
作者
Campbell, B. [1 ]
Davis, S. R. [2 ]
Abramson, M. J. [2 ]
Mishra, G. [3 ]
Handelsman, D. J. [4 ]
Perret, J. L. [1 ]
Dharmage, S. C. [1 ]
机构
[1] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia
[4] Univ Sydney, Concord Hosp, ANZAC Res Inst, Concord, NSW, Australia
关键词
Menopause; respiratory; asthma; chronic obstructive pulmonary disease; lung function; C-REACTIVE PROTEIN; HORMONE REPLACEMENT THERAPY; OF-THE-LITERATURE; PULMONARY-FUNCTION; TNF-ALPHA; METABOLIC SYNDROME; SEX-DIFFERENCES; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; AIRWAY RESPONSIVENESS;
D O I
10.1080/13697137.2017.1392504
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The menopausal transition may have significant consequences for respiratory health, risk of chronic respiratory disease and management strategies. Objective: To systematically summarize the literature regarding the impact of menopause status on respiratory health outcomes. Methods: PubMed was searched systematically to identify population-based studies investigating the associations between menopause status and respiratory outcomes including asthma, chronic obstructive pulmonary disease (COPD), respiratory symptoms and lung function. Results: Ten publications were identified for full review. Evidence on menopause and asthma was conflicting, while studies on COPD were scarce. The findings generally support an association between menopause and clinically significant reductions in lung function in a non-obstructive pattern. However, the effects of menopause are clouded by aging, menopausal hormone therapy use, and increased risk of metabolic syndrome during this period. Conclusions: As the global burden associated with respiratory conditions continues to rise, the need to understand the associations between menopause and respiratory health is essential to identify potentially modifiable risk factors for respiratory disease in adult women. More studies are needed to clarify the impact of menopause on obstructive lung disease.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 95 条
[1]   C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure [J].
Aksu, Funda ;
Capan, Nermin ;
Aksu, Kurtulus ;
Ofluoglu, Ruhsar ;
Canbakan, Sema ;
Yavuz, Bunyamin ;
Akin, Kadir Okhan .
JOURNAL OF THORACIC DISEASE, 2013, 5 (04) :414-421
[2]   Lower lung function associates with cessation of menstruation: UK Biobank data [J].
Amaral, Andre F. S. ;
Strachan, David P. ;
Real, Francisco Gomez ;
Burney, Peter G. J. ;
Jarvis, Deborah L. .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (05) :1288-1297
[3]  
[Anonymous], 2017, Chronic obstructive pulmonary disease (copd)
[4]   Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome [J].
Aronson, D ;
Bartha, P ;
Zinder, O ;
Kerner, A ;
Markiewicz, W ;
Avizohar, O ;
Brook, GJ ;
Levy, Y .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (05) :674-679
[5]   Role of tumor necrosis factor alpha in asthma [J].
Babu, KS ;
Davies, DE ;
Holgate, ST .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (04) :583-+
[6]  
Ballard K, 2002, BRIT J GEN PRACT, V52, P835
[7]  
Balzano G, 2007, Monaldi Arch Chest Dis, V67, P135
[8]   Asthma and sex hormones [J].
Balzano, G ;
Fuschillo, S ;
Melillo, G ;
Bonini, S .
ALLERGY, 2001, 56 (01) :13-20
[9]   THE EFFECT OF PULMONARY IMPAIRMENT ON ALL-CAUSE MORTALITY IN A NATIONAL COHORT [J].
BANG, KM ;
GERGEN, PJ ;
KRAMER, R ;
COHEN, B .
CHEST, 1993, 103 (02) :536-540
[10]  
Bellia V, 2016, MONALDI ARCH CHEST D, V67, P125